Physician

Todd Andrew Levin, M.D.

According to 2025 Medicare claims, Todd Levin, M.D. (NPI: 1487623989) practices allergy/immunology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is CHATTANOOGA ALLERGY CLINIC , PLLC (NPI: 1770594129; TIN: 621870857) and primary practice location at 37421-2423. Levin is affiliated with the CommonSpirit ACO III (ACO ID: A2645), participating under the MSSP model.

Levin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 62,039 HCPCS/CPT codes, and received $1,309,233 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,748 prescription claims across 930 beneficiaries totaling $2,176,701 in drug costs, led by Xolair (Omalizumab). DME data shows 370 claims. Open Payments data shows 110 records totaling $12,123. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $125,396 to $1,309,233. Similarly, Part D prescription costs have moved sharply higher in recent years, from $473,131 to $2,176,701. In contrast, DME billing represents a smaller volume and rose steadily, from $3,470 to $9,528.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	306	14,452	$125,396
2016	365	18,255	$154,621
2017	413	21,590	$183,916
2018	446	21,294	$195,079
2019	509	27,885	$421,390
2020	512	32,687	$540,641
2021	565	34,754	$825,229
2022	527	34,054	$841,035
2023	530	41,667	$1,054,505
2024	549	62,039	$1,309,233

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	401	3,265	$473,131
2016	430	3,346	$568,887
2017	532	4,068	$746,525
2018	561	4,316	$862,938
2019	691	4,580	$1,005,292
2020	850	5,194	$1,236,511
2021	924	5,563	$1,512,407
2022	891	5,652	$1,798,366
2023	869	5,924	$2,384,055
2024	930	5,748	$2,176,701

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	327	$344,878
2016	12	394	$333,529
2017	27	461	$324,545
2018	N/R	336	$267,625
2019	11	420	$364,695
2020	34	463	$370,039
2021	N/R	511	$467,205
2022	26	502	$488,719
2023	26	444	$502,232
2024	23	370	$458,010

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	212	274	$86
94010	Test to measure expiratory airflow and volume	121	148	$18
95012	Test to measure the level of nitric oxide gas	160	191	$13
95165	Professional service for preparation and provision of 1 or more antigens	316	7,728	$10
95117	Professional service for multiple injections of allergen	346	7,287	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	109	3,052	$475,710
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	389	15,540	$323,979
Tezspire	Tezepelumab-Ekko	70	1,960	$286,079
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	138	4,831	$99,267
Fasenra	Benralizumab	16	896	$94,800

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	59	$191,427
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	43	$151,312
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	19	$53,288
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$52,910
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	11	112	$7,885

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	110	$12,123	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Todd Andrew Levin, M.D.?

Tedicare shows public-source Medicare data for Todd Andrew Levin, M.D. (NPI 1487623989), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Todd Andrew Levin, M.D. have ACO affiliation data?

Todd Andrew Levin, M.D. is shown with ACO affiliation data for CommonSpirit ACO III (MSSP, ACO ID A2645).

What billing organization is linked to Todd Andrew Levin, M.D.?

Todd Andrew Levin, M.D. is linked to CHATTANOOGA ALLERGY CLINIC , PLLC (billing NPI 1770594129) in the available physician profile data.

Does Todd Andrew Levin, M.D. have Open Payments data?

Todd Andrew Levin, M.D. has 110 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.